Research Peptide SELANK 10MG

Selank 10mg (Research Grade)
Selank is a synthetic peptide studied in the literature for its effects on neurochemical signalling and behaviour-related pathways. Published preclinical and small human studies have explored it in areas such as anxiolytic-like activity, cognition, and central nervous system signalling, but the evidence base remains limited and does not support broad consumer health claims.

Research context:
Public interest in Selank often presents it as a nootropic or calming compound, but the stronger published support is still mainly experimental rather than mainstream, large-scale clinical evidence. In the US regulatory context, FDA has specifically flagged selank acetate (TP-7) in compounding-related safety discussions, noting potential immunogenicity concerns and that the agency lacks important safety information regarding administration to humans.

Important notice:
For laboratory research use only. Not for human consumption, injection, therapeutic, diagnostic, or veterinary use. Any references to mechanism or biological activity are provided for scientific context only and do not imply safety, efficacy, or approved medical benefit. FDA warning-letter materials have also noted that compounded products containing Selank were not eligible for certain statutory exemptions because Selank was not the subject of an applicable USP/NF monograph, was not a component of an FDA-approved human drug, and did not appear on the 503A bulks list in that context.